tirzepatide glaucoma Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Open-Angle Glaucoma Clermont | Narrow-Angle

Apalaki 1,2 , C.M

Notably, this elevation occurs well before the pathological accumulation of conventional biomarkers such as A and tau, highlighting its potential for early disease detection

"You might lose a good amount of weight right away, but your metabolism quickly goes into survival mode." The change in the metabolism is a key reason why people regain weight after dieting

Timestamped Show Notes [00:00:00] Introduction - Brittany's home office with plants and dogs [02:02] The "holistic" medicine debate [04:02] Why Brittany opened Sweetgrass Psychiatry [07:00] Bringing family medicine in-house [10:01] The economics of integrating primary care [11:08] Scaling to 30 clinicians [13:41] Full suite of interventional services offered [15:08] Nine out of twenty patients on GLP-1s [16:15] Depression and metabolic syndrome: 50/50 overlap [19:03] GLP-1s and the mesolimbic system [20:24] JAMA Psychiatry study on semaglutide for alcohol use disorder [21:17] Dr

A balanced plan combining lean protein, healthy fats, fiber, and moderate portions works best alongside Ozempic